Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (17 ops.)
Latest filing published 05 Oct 2026 for Immunovant, Inc., €1.2M. Read the official filing
Filing timeline
BuySaleEric Venker
Insider track record
Disclosed buys
0
Disclosed sells
17
Signal history
Eric Venker: trading record in brief
Eric Venker (chief executive) discloses dealings in 2 companies, chiefly Roivant Sciences Ltd. and Immunovant, Inc. In total, 92 filings cover trades dated from 25 March 2022 to 2 October 2026.
Every open-market trade on record is a sale: 17 sales worth €19.5M. Outside the open market, there are 25 share grants and 38 option exercises. So far in 2026, the count stands at no purchases and 5 sales.
The latest filing, published on 5 October 2026, reports an option exercise of €1.2M in Immunovant, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Eric Venker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations92 total
92,187 shares@ US$14.460.019% mcap9.3% of flowCommon StockSEC:0001764013-26-000110:0
85,886 shares@ US$33.650.041% mcap20.2% of flowCommon StockSEC:0001764013-26-000110:1
3,506 shares@ US$34.110.0017% mcap0.8% of flowCommon StockSEC:0001764013-26-000110:2
200,000 shares@ US$3.850.0029% mcap0.9% of flowCommon SharesSEC:0001635088-26-000108:0
200,000 shares@ US$36.620.028% mcap8.2% of flowCommon SharesSEC:0001635088-26-000108:1
13,909 shares@ US$36.840.0019% mcap0.7% of flowCommon SharesSEC:0001140361-26-034238:0
200,000 shares@ US$3.850.0030% mcap1.0% of flowCommon SharesSEC:0001140361-26-030107:0
200,000 shares@ US$34.950.027% mcap9.3% of flowCommon SharesSEC:0001140361-26-030107:1
92,188 shares@ US$14.460.019% mcap13.3% of flowCommon StockSEC:0001764013-26-000077:0
86,629 shares@ US$38.140.047% mcap33.1% of flowCommon StockSEC:0001764013-26-000077:1
3,092 shares@ US$38.480.0017% mcap1.2% of flowCommon StockSEC:0001764013-26-000077:2
200,000 shares@ US$3.850.0029% mcap1.0% of flowCommon SharesSEC:0001635088-26-000044:0
200,000 shares@ US$29.590.022% mcap7.7% of flowCommon SharesSEC:0001635088-26-000044:1
232,252 shares0Common StockSEC:0001764013-26-000034:0
368,750 shares@ US$14.460.058% mcap52.4% of flowCommon StockSEC:0001764013-26-000024:0
200,000 shares@ US$3.851.0% of flowCommon SharesSEC:0001635088-26-000026:0
7,051 shares@ US$27.150.2% of flowCommon SharesSEC:0001635088-26-000022:0
200,000 shares@ US$3.851.0% of flowCommon SharesSEC:0001635088-26-000017:0
200,000 shares@ US$3.851.0% of flowCommon SharesSEC:0001140361-26-001239:0
313,841 shares@ US$3.851.6% of flowCommon SharesSEC:0001140361-25-046786:0
200,000 shares@ US$3.851.0% of flowCommon SharesSEC:0001140361-25-045279:0
7,051 shares@ US$20.270.2% of flowCommon SharesSEC:0001140361-25-043201:0
200,000 shares@ US$3.851.0% of flowCommon SharesSEC:0001140361-25-041214:0
414,683 shares@ US$15.858.6% of flowCommon SharesSEC:0001140361-25-038545:0
104,940 shares@ US$15.852.2% of flowCommon SharesSEC:0001140361-25-038126:0
25 of 92 declarations
